Table 6.
Measure | Ratio (95 % CI) |
---|---|
Proportional reporting ratio | 3.74 (1.54–9.07) |
Relative odds ratio | 3.74 (1.54–9.08) |
Relative reporting ratio | 3.68 (1.52–8.92) |
H2 receptor antagonist-associated SCLE cases = 7/220
CI confidence interval
Measure | Ratio (95 % CI) |
---|---|
Proportional reporting ratio | 3.74 (1.54–9.07) |
Relative odds ratio | 3.74 (1.54–9.08) |
Relative reporting ratio | 3.68 (1.52–8.92) |
H2 receptor antagonist-associated SCLE cases = 7/220
CI confidence interval